Research ArticleClinical Studies

The CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for Gastric Cancer Patients who Receive Curative Treatment

TORU AOYAMA, YUKIO MAEZAWA, ITARU HASHIMOTO, KENTARO HARA, AYAKO TAMAGAWA, KEUSIKE KAZAMA, AYA KATO, HARUHIKO CHO, MASATO NAKAZONO, MASAKATSU NUMATA, SHINNOSUKE KAWAHARA, MIE TANABE, JYUNYA MORITA, TAKASHI OSHIMA, AYA SAITO, NORIO YUKAWA and YASUSHI RINO
Anticancer Research April 2024, 44 (4) 1629-1636; DOI: https://doi.org/10.21873/anticanres.16961

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
The CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for Gastric Cancer Patients who Receive Curative Treatment
TORU AOYAMA, YUKIO MAEZAWA, ITARU HASHIMOTO, KENTARO HARA, AYAKO TAMAGAWA, KEUSIKE KAZAMA, AYA KATO, HARUHIKO CHO, MASATO NAKAZONO, MASAKATSU NUMATA, SHINNOSUKE KAWAHARA, MIE TANABE, JYUNYA MORITA, TAKASHI OSHIMA, AYA SAITO, NORIO YUKAWA, YASUSHI RINO
Anticancer Research Apr 2024, 44 (4) 1629-1636; DOI: 10.21873/anticanres.16961
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords